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Mitochondria contain about 1000 different proteins. 99% of the
proteins are synthesized as precursors on cytosolic ribosomes. The
precursors are imported via the translocase of the outer mitochon-
drial membrane (TOM complex) and are subsequently sorted into
the four mitochondrial subcompartments, outer membrane, inter-
membrane space, inner membrane and matrix. (i) Cleavable
preproteins are transported from the TOM complex to the
presequence translocase of the inner membrane (TIM23 complex).
The presequence translocase-associated motor (PAM) drives trans-
location into the matrix. (ii) Hydrophobic inner membrane proteins
are transferred through the intermembrane space by a chaperone
complex (small Tim proteins) and inserted into the inner membrane
by the TIM22 complex. (iii) The mitochondrial import and assembly
machinery (MIA) directs small proteins into the intermembrane
space and promotes the formation of disulﬁde bonds. (iv) Beta-
barrel proteins are transported from the TOM complex to the
sorting and assembly machinery of the outer membrane (SAM
complex).
doi:10.1016/j.bbabio.2008.05.016
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A strikingly large number of mitochondrial DNA (mtDNA)
mutations have been found to be the cause of respiratory chain
and oxidative phosphorylation defects. These mitochondrial dis-
orders were the ﬁrst to be investigated after the small mtDNA had
been sequenced in the 80's. Only recently numerous diseases
resulting from mutations in nuclear genes encoding mitochondrial
proteins have been characterized. Among these, nine are caused by
defects of mitochondrial carriers, a family of nuclear-coded proteins
that shuttle a variety of metabolites across the mitochondrial
membrane. Mutations of mitochondrial carrier genes involved in
mitochondrial functions other than oxidative phosphorylation are
responsible for carnitine/acylcarnitine carrier deﬁciency, HHH
syndrome, aspartate/glutamate isoform deﬁciency, Amish microce-
phaly and neonatal myoclonic epilepsy; these disorders are
characterised by speciﬁc metabolic dysfunctions, depending on the
physiological role of the affected carrier in intermediary metabo-
lism. Defects of mitochondrial carriers that supply mitochondria
with the substrates of oxidative phosphorylation, inorganic phos-
phate and ADP, are responsible for diseases characterised by
defective energy production. Herein, all the mitochondrial carrier-
associated diseases known to date are reviewed for the ﬁrst time.
Particular emphasis is given to the molecular basis and pathogenetic
mechanism of these inherited disorders.
doi:10.1016/j.bbabio.2008.05.017
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Photosystem II, the water oxidising enzyme of photosynthesis,
put the energy (or at least a major fraction of it) into the biosphere
and the oxygen into the atmosphere. It is certainly one the most
inﬂuential and important enzymes on the planet. The aim of our
research is to understand how this enzyme works as 1) a solar
energy converter and 2) the only known thermodynamically
efﬁcient catalyst for oxidizing water. The information obtained is
used in the design of artiﬁcial catalysts and photocatalysts. A
chemical catalyst that has the thermodynamic efﬁciency of the
enzyme could greatly improve the efﬁciency of 1) water electrolysis
and photolysis for fuel (e.g. H2) production and 2) the reverse
reaction, oxygen reduction, in fuel cells. There is therefore a great
interest in understanding the mechanism of this enzyme and in
reproducing aspects of its function in artiﬁcial systems. I will
describe our current knowledge of Photosystem II, including some
recent experimental studies, as well as recent efforts in our joint
Saclay/Orsay program aimed at producing bio-inspired water
oxidizing catalysts.
doi:10.1016/j.bbabio.2008.05.018
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The photosynthetic unit of purple photosynthetic bacteria
typically contains two types of light-harvesting complexes, called
LH1 and LH2. These antenna complexes are constructed on a
modular principle. They are circular or elliptical oligomers of dimers
of two low-molecular weight, hydrophobic apoproteins, called a and
b, that bind bacteriochlorophylls and carotenoids non-covalently.
The LH1 complex surrounds the reaction centre and, depending on
the species, is either a monomer or a dimer. The LH2 complexes are
arranged around the LH1-RC complexes. This plenary lecture will
present the current status of structural studies on these pigment-
protein complexes, based upon a combination of X-ray crystal-
lography and single molecule spectroscopy. Then an overall view of
how they are arranged in their native photosynthetic membranes
will be presented.
doi:10.1016/j.bbabio.2008.05.019
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Complex I (NADH:ubiquinone oxidoreductase) is the ﬁrst enzyme
of the respiratory electron transport chain in mitochondria. It
catalyses the reduction of ubiquinone by NADH, coupled to the
translocation of four protons across the inner-mitochondrial mem-
brane, and it is a signiﬁcant source of reactive oxygen species, linked
to neuromuscular diseases and ageing. In bovine mitochondria
complex I comprises 45 different subunits, a ﬂavin mononucleotide
at the active site where NADH is oxidised, and eight iron sulphur
clusters. This talk will focus on the mechanism of the redox reaction
in the enzyme (the mechanism of proton translocation remains
unknown). The structure of the hydrophilic domain of complex I
from Thermus thermophilus has provided a framework for under-
standing the redox reaction, and it makes the pathway that the
electrons take through the enzyme easy to visualise. However, it does
not identify rate limiting steps, or describe the reaction intermediates
formed and the free energy changes as the reaction progresses. A
mechanistic understanding at this level is crucial for understanding
how complex I conserves the potential difference between NADH and
ubiquinone as a proton motive force so effectively, for deﬁning how
electron and proton transfer are coupled, and for understanding the
formation of reactive oxygen species. This talk will describe current
understanding and new information about the mechanism of the
redox reaction in complex I.
doi:10.1016/j.bbabio.2008.05.020
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The molecular mechanism how complex I (NADH:ubiquinone
oxidoreductase) links electron transfer to proton translocation is
still elusive. We have established the strictly aerobic yeast Yarrowia
lipolytica as a powerful genetic system to study structure, function
and biogenesis of this mitochondrial complex I. The ubiquinone
reducing catalytic core of complex I resides at the interface
between the 49-kDa and the PSST subunit of the peripheral arm
where iron–sulfur cluster N2 serves as the immediate reductant of
ubiquinone. In an extensive mutagenesis study based on the
recently published partial structure of bacterial complex I, we
have identiﬁed the entry pathway for ubiquinone and domains
interacting with hydrophobic complex I. Single particle analysis of
antibody decorated complex I indicated that the 49-kDa subunit is
located surprisingly far away from the membrane arm. This
unexpected result was conﬁrmed by further structural studies
with a subcomplex of complex I lacking the 51-kDa and 24-kDa
subunits. Electron microscopic 3D reconstructions of this subcom-
plex allowed positioning the partial structure of the bacterial
complex within Y. lipolytica complex I. Therefore, we propose that
ubiquinone reaches its site of reduction via a hydrophobic ramp or
channel within complex I. We propose a two-state mechanism of
energy conservation for complex I that is based on long range
conformational changes of the enzyme driven by stabilization
changes of ubiquinone intermediates.
doi:10.1016/j.bbabio.2008.05.021
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Mitochondrial diseases are genetically and phenotypically hetero-
geneous. The human mitochondrial DNA (mtDNA) tRNALeu(UUR)
G3243A mutation causes diabetes at low heteroplasmy but MELAS
at high heteroplasmy, the two phenotypes associated with differences
in nuclear DNA (nDNA) and mtDNA gene MITOCHIP gene expression
proﬁles. Inactivation of the mouse heart–muscle–brain isoform of the
adenine nucleotide translocator (Ant1) results in mitochondrial
myopathy and cardiomyopathy associated with defects in mitochon-
drial ADP–ATP exchange and increased mitochondrial reactive oxygen
species (ROS) production. MITOCHIP expression analysis of Ant1-
deﬁcient skeletal muscle revealed the coordinate up-regulation of
mtDNA and nDNA oxidative phosphorylation, antioxidant and anti-
apoptotic genes and the down-regulation of glycolytic and pro-
apoptotic genes, all in association with increased protein levels for
Pgc-1α, Nrf1, myogenin, and Tfam but reduced levels of c-myc.
Neurons from Ant1-deﬁcient mice were more resistant to glutamate
and etoposide induced apoptosis and Ant1-deﬁcient mice were less
sensitive to kainic acid excitotoxicity. Mice harboring a heteroplasmic
mtDNA ND6 frameshift mutation (nt 13885insC) showed directional
loss of the mutant mtDNAs from the female germline in subsequent
liters and generations implying intra-ovarian selection against
severely deleterious mtDNA mutations. By contrast, a COI nt T6589C
missence mutation (V421A) was retained and resulted in the
development of mitochondrial myopathy and cardiomyopathy and
neuronal cell loss. Therefore, mutations in different mitochondrial
genes can produce similar tissue phenotypes, perhaps reﬂecting
similar gene expression proﬁles.
doi:10.1016/j.bbabio.2008.05.022
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We have developed a new method to quantify the transmem-
brane electrochemical proton gradient present in chloroplasts of
dark-adapted leaves. When a leaf is illuminated by a short pulse of
in ten s e l ig h t, we ob se rved that the light-induced membrane
potential change reaches a maximum value (~190 mV) determined
by ion leaks that occur above a threshold level of the electro-
chemical proton gradient. After the light-pulse, the decay of the
membrane potential displays a marked slowdown, which reﬂects
the switch from an activated to an inactivated state of the ATP




that preexists in the dark (40 to 70 mV), which collapses upon
addition of inhibitors of the respiratory chain. Thus, it shows that it
results from the hydrolysis of ATP of mitochondrial origin.
Illumination of the leaf induces a Δ
~
µH
+ increase (up to ~150 mV)
that reﬂects the light-induced increase in ATP concentration.
Following the illumination, Δ
~
µH
+ relaxes to its dark-adapted value
according to a multiphasic kinetics completed in more than 1 h. In
mature leaf, the deactivation of the Benson–Calvin cycle follows
similar kinetics as Δ
~
µH
+ decay, showing that its state of activation is
mainly controlled by ATP concentration.
doi:10.1016/j.bbabio.2008.05.023
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